Skip to main content

Find Clinical Trials

Home
Conditions
Carcinoma, Bronchogenic

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,193 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung Cancer

NCT01951586

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Research Site Goodyear, Arizona, United States

Research Site Anaheim, California, United States

Research Site Long Beach, California, United States

Research Site Los Angeles, California, United States

View all 74 locations

View Trial Details

Completed

UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients

NCT03158883

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: UC Davis Sacramento, California, United States

View Trial Details

Completed

Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer

NCT01797159

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +10 more
Locations: Bayview Medical Center Baltimore, Maryland, United States

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung Cancer

NCT01911507

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University of California, Davis Sacramento, California, United States

UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)

NCT01454102

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Ucla Los Angeles, California, United States

Yale University New Haven, Connecticut, United States

H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

A Phase I Trial of Vandetanib (AZD6474) and Selumetinib (AZD6244) for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1)

NCT01586624

Conditions: Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +9 more
Locations: Churchill Hospital Headington, Oxford, United Kingdom

Addenbrooke's Hospital Cambridge, United Kingdom

The Christie Hospital Manchester, United Kingdom

Freeman Hospital Newcastle, United Kingdom

View Trial Details

Completed

Study of Two Doses of Pembrolizumab (MK-3475) Versus Docetaxel in Previously Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)

NCT01905657

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Not specified

View Trial Details

Completed

Nab-Paclitaxel in Combination With Carboplatin as First-line Therapy in Patients With NSCLC

NCT02799862

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: iOMEDICO Freiburg im Breisgau, Baden-Wurttemberg, Germany

View Trial Details

Completed

Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers

NCT00365963

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University of Wisconsin- Madison 610 Walnut St, WARF 1109A Madison, Wisconsin, United States

View Trial Details

Completed

Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy

NCT03911219

Conditions: Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +15 more
Locations: Onkologische Praxis im St. Marien-Krankenhaus Ahaus, Germany

Gesundheitszentrum St. Marien Amberg, Germany

Klinikum Arnsberg, Karolinen Hospital Arnsberg, Germany

MVZ am Klinikum Aschaffenburg Aschaffenburg, Germany

View all 92 locations

View Trial Details